Save items

loading

Similar articles in PubMed

Canada's implementation of the Paragraph 6 Decision: is it sustainable public policy?[Global Health. 2007]
Cohen-Kohler JC, Esmail LC, Cosio AP. Global Health. 2007 Dec 6; 3:12. Epub 2007 Dec 6.
Framing access to medicines in developing countries: an analysis of media coverage of Canada's Access to Medicines Regime.[BMC Int Health Hum Rights. 2010]
Esmail LC, Phillips K, Kuek V, Cosio AP, Kohler JC. BMC Int Health Hum Rights. 2010 Jan 4; 10:1. Epub 2010 Jan 4.
A one-time-only combination: Emergency medicine exports and the TRIPS agreement under Canada's access to medicines regime.[Health Hum Rights. 2010]
Weber A, Mills L. Health Hum Rights. 2010 Jun 15; 12(1):109-22. Epub 2010 Jun 15.
[Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines].[Cad Saude Publica. 2007]
Chaves GC, Oliveira MA, Hasenclever L, de Melo LM. Cad Saude Publica. 2007 Feb; 23(2):257-67.
Affordable antiretroviral drugs for the under-served markets: how to expand equitable access against the backdrop of challenging scenarios?[Curr HIV Res. 2006]
Dionisio D, Cao Y, Hongzhou L, Kraisintu K, Messeri D. Curr HIV Res. 2006 Jan; 4(1):3-20.

See reviews...See all...

Cited by other articles in PMC

Framing and the health policy process: a scoping review[Health Policy and Planning. 2016]
Koon AD, Hawkins B, Mayhew SH. Health Policy and Planning. 2016 Feb 11; 31(6): 801-816
Canada and access to medicines in developing countries: intellectual property rights first[Globalization and Health. 2013]
Lexchin J. Globalization and Health. 2013 Sep 3; 9: 42

See all...

Links

MedGen
MedGen
Related information in MedGen
PubMed
PubMed
PubMed citations for these articles
Taxonomy
Taxonomy
Related taxonomy entry

Recent Activity

Clear Turn Off Turn On

The politics behind the implementation of the WTO Paragraph 6 Decision in Canada...
The politics behind the implementation of the WTO Paragraph 6 Decision in Canada to increase global drug access
Globalization and Health. 2012; 8()7

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries.[Bull World Health Organ. 2007]

Mendis S, Fukino K, Cameron A, Laing R, Filipe A Jr, Khatib O, Leowski J, Ewen M

Bull World Health Organ. 2007 Apr; 85(4):279-88.

A tragically naive Canadian law for tragically neglected global health.[CMAJ. 2007]

Attaran A

CMAJ. 2007 Jun 5; 176(12):1726-7.
Delivery past due: global precedent set under Canada's Access to Medicines Regime.[HIV AIDS Policy Law Rev. 2008]

Elliott R

HIV AIDS Policy Law Rev. 2008 Jul; 13(1):1, 5-12.

Should access to medicines and TRIPS flexibilities be limited to specific diseases?[Am J Law Med. 2008]

Outterson K

Am J Law Med. 2008; 34(2-3):279-301.

After compulsory licensing: coming issues in Canadian pharmaceutical policy and politics.[Health Policy. 1997]

Lexchin J

Health Policy. 1997 Apr; 40(1):69-80.

After compulsory licensing: coming issues in Canadian pharmaceutical policy and politics.[Health Policy. 1997]

Lexchin J

Health Policy. 1997 Apr; 40(1):69-80.
Pharmaceuticals, patents, and politics: Canada and Bill C-22.[Int J Health Serv. 1993]

Lexchin J

Int J Health Serv. 1993; 23(1):147-60.

Right idea, wrong result--Canada's access to medicines regime.[Am J Law Med. 2008]

Goodwin PE

Am J Law Med. 2008; 34(4):567-84.

Review Soaring antiretroviral prices, TRIPS and TRIPS flexibilities: a burning issue for antiretroviral treatment scale-up in developing countries.[Curr Opin HIV AIDS. 2010]

Orsi F, d'almeida C

Curr Opin HIV AIDS. 2010 May; 5(3):237-41.